Journals / Genel Tıp Dergisi / 2023 / Cilt: 33 Sayı: 4

Juglone Effects by Dual Way on mTOR Gene Expression, Which Plays Central Role in Cell Growth, Survival and Metabolism, in PANC-1 and BxPC-3 Pancreatic Cancer Cell Lines

Juglon, PANC-1 ve BxPC-3 Pankreas Kanser Hücre Hatlarında Hücre Büyümesi, Hayatta Kalma ve Metabolizmada Merkezi Rol Oynayan mTOR Gen İfadesine İki Yönlü Etki Eder

Pages
353–359
Publication Date
2023-08-31
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Our findings suggest that juglone has a developable potential and is a promising theurapeutic agent to develop new strategies for the battle with cancer with those effects on mTOR gene which plays a central role in cellular homeostasis and several cellular events including cell growth, survival and metabolism.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background/Aims: Juglone, as a naphthoquinone, has been shown to have cytotoxic and apoptotic effects in various cancer cells and besides this effects it was reported to have anti-invasive and anti-metastatic effects in PANC-1 and BxPC-3 cells in our previous studies.
📊
Key Findings & Data:In this study, we investigated the effects of juglone on GRP75, TFAM and mTOR genes encoding key proteins associated with mitochondrial biogenesis and activation in PANC-1 and BxPC-3 pancreatic cancer cells since mitochondria has central roles in cancer cell survival, metastasis and therapeutic resistance.
💡
Conclusion & Impact:Conclusion: Our findings suggest that juglone has a developable potential and is a promising theurapeutic agent to develop new strategies for the battle with cancer with those effects on mTOR gene which plays a central role in cellular homeostasis and several cellular events including cell growth, survival and metabolism.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Juglone · Pancreatic cancer · Mitochondrial biogenesis

Abstract

Background/Aims: Juglone, as a naphthoquinone, has been shown to have cytotoxic and apoptotic effects in various cancer cells and besides this effects it was reported to have anti-invasive and anti-metastatic effects in PANC-1 and BxPC-3 cells in our previous studies. In this study, we investigated the effects of juglone on GRP75, TFAM and mTOR genes encoding key proteins associated with mitochondrial biogenesis and activation in PANC-1 and BxPC-3 pancreatic cancer cells since mitochondria has central roles in cancer cell survival, metastasis and therapeutic resistance. Methods: In our study; 5, 10, 15 and 20 μM juglone doses were selected as the application doses considering the IC50 value determined after MTT test results and the expressions of the target genes were analyzed by qPCR method after application of juglone doses for 24 hours. Results: Our study results revealed that juglone had an opposite and strong effects on mTOR expression in both cell lines. Conclusion: Our findings suggest that juglone has a developable potential and is a promising theurapeutic agent to develop new strategies for the battle with cancer with those effects on mTOR gene which plays a central role in cellular homeostasis and several cellular events including cell growth, survival and metabolism.

Özet

Arkaplan/Hedefler: Bir naftakinon olarak juglonun çeşitli kanser hücrelerinde sitotoksik ve apoptotik etkisi gösterilmiş, daha önceki araştırmalarımızda PANC-1 ve BxPC-3 hücrelerinde bu etkilerinin yanı sıra anti-invaziv ve anti-metastatik etki gösterdiği rapor edilmiştir. Bu çalışmada kanser hücrelerinin sağkalımı, metastaz ve tedaviye direnç gelişmesi süreçlerinde merkezi rolü olan mitokondrial biyogenez ve aktivasyon ile ilişkili anahtar proteinleri kodlayan GRP75, TFAM ve mTOR genleri üzerine juglonun etkileri PANC-1 ve BxPC-3 pankreas kanseri hücre hatlarında araştırılmıştır. Metodlar: Çalışmamızda MTT testi sonuçlarından elde edilen IC50 değeri dikkate alınarak 5, 10, 15 ve 20 μM juglon dozları uygulama dozu olarak seçilmiş ve juglonun belirlenen dozlardaki 24 saatlik uygulamasından sonra hedef genlerin ifadeleri qPCR yöntemiyle incelenmiştir. Bulgular: Çalışma sonuçlarımız, juglonun her iki hücre hattında da mTOR ekspresyonu üzerinde zıt ve güçlü bir etkiye sahip olduğunu ortaya koydu. Sonuç: Çalışma bulgularımız, hücresel homeostazda, hücre büyümesi, hayatta kalması ve metabolizması dahil olmak üzere bir dizi hücresel olayda merkezi rol oynayan mTOR ifadesi üzerindeki bu etkileri ile juglonun geliştirilebilir bir potansiyele sahip olduğu ve pankreas kanseri ile savaşta yeni stratejiler için umut vaad eden bir teröpotik ajan olduğu düşüncemizi desteklemektedir.

🔖

Cite This Article

BÜYÜKTÜT, E. M. D., KAYA, D. E., GÖKTÜRK, F., ARIKOĞLU, H. (2023). Juglone Effects by Dual Way on mTOR Gene Expression, Which Plays Central Role in Cell Growth, Survival and Metabolism, in PANC-1 and BxPC-3 Pancreatic Cancer Cell Lines. Genel Tıp Dergisi, Cilt: 33 Sayı: 4, 353–359. https://ajindex.com/articles/961251

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Rahib L, Smith BD, Aizenberg R, et al. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer research. 2014;74:2913-21.
  2. Del Chiaro M, Rangelova E, Halimi A, et al. Pancreatectomy with arterial resection is superior to palliation in patients with borderline resectable or locally advanced pancreatic cancer. HPB: the official journal of the International Hepato Pancreato Biliary Association. 2019;21:219-25.
  3. Foley K, Kim V, Jaffee E, Zheng L. Current progress in immunotherapy for pancreatic cancer. Cancer letters. 2016;381:244-51.
  4. Siegel R, Miller KD, Sauer A. Cancer facts & figures 2020. CA Cancer J Clin. 2020;70:7-30.
  5. Oldfield LE, Connor AA, Gallinger S. Molecular Events in the Natural History of Pancreatic Cancer. Trends in cancer. 2017;3:336-46.
  6. Sarvepalli D, Rashid MU, Rahman AU, et al. Gemcitabine: A Review of Chemoresistance in Pancreatic Cancer. Critical reviews in oncogenesis. 2019;24:199-212.
  7. Ahmad T, Suzuki YJ. Juglone in Oxidative Stress and Cell Signaling. Antioxidants (Basel, Switzerland). 2019;8. Bhargava UC, Westfall BA. Antitumor activity of Juglans niga (black walnut) extractives. Journal of pharmaceutical sciences. 1968;57:1674-7.
  8. Cenas N, Prast S, Nivinskas H, Sarlauskas J, Arnér ES. Interactions of nitroaromatic compounds with the mammalian selenoprotein thioredoxin reductase and the relation to induction of apoptosis in human cancer cells. The Journal of biological chemistry. 2006;281:5593-603.
  9. Xu H, Yu X, Qu S, Sui D. Juglone, isolated from Juglans mandshurica Maxim, induces apoptosis via down-regulation of AR expression in human prostate cancer LNCaP cells. Bioorganic & medicinal chemistry letters. 2013;23:3631-4.
  10. Vyas S, Zaganjor E, Haigis MC. Mitochondria and Cancer. Cell. 2016;166:555-66.
  11. Porporato PE, Filigheddu N, Pedro JMB, Kroemer G, Galluzzi L. Mitochondrial metabolism and cancer. Cell research. 2018;28:265-80.
  12. Avcı E, Arıkoğlu H, Erkoç Kaya D. Investigation of juglone effects on metastasis and angiogenesis in pancreatic cancer cells. Gene. 2016;588:74-8.
  13. Gokturk F, Erkoc-Kaya D, Arikoglu H. Juglone can inhibit angiogenesis and metastasis in pancreatic cancer cells by targeting Wnt/β-catenin signaling. Bratislavske lekarske listy. 2021;122:132-7.
  14. Dai Y, Li F, Jiao Y, et al. Mortalin/glucose-regulated protein 75 promotes the cisplatin-resistance of gastric cancer via regulating anti-oxidation/apoptosis and metabolic reprogramming. Cell death dis